West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · WST · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
2
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
West Pharmaceutical Services, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
WST insider buying and selling by quarter
WST insider selling · WST insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · WST ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
WST executive sell shares · WST board member insider trading · WST insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 12, 2026 | Campbell Shane Alden SVP, Proprietary Segment | Option | 473.593 | — | Form 4 |
| May 12, 2026 | Campbell Shane Alden SVP, Proprietary Segment | Other | 134.927 | $42K | Form 4 |
| May 12, 2026 | Campbell Shane Alden SVP, Proprietary Segment | Option | 295.995 | — | Form 4 |
| May 12, 2026 | Campbell Shane Alden SVP, Proprietary Segment | Other | 84.329 | $26K | Form 4 |
| May 4, 2026 | Pucci Paolo Director | Award | 791 | — | Form 4 |
| May 4, 2026 | Michels Douglas A Director | Award | 791 | — | Form 4 |
| May 4, 2026 | Lockhart Stephen H Director | Award | 791 | — | Form 4 |
| May 4, 2026 | LAI GOLDMAN MYLA Director | Award | 791 | — | Form 4 |
| May 4, 2026 | Keller Deborah L Director | Award | 791 | — | Form 4 |
| May 4, 2026 | Joseph Molly Director | Award | 791 | — | Form 4 |
| May 4, 2026 | HAUGEN JANET BRUTSCHEA Director | Award | 791 | — | Form 4 |
| May 4, 2026 | FRIEL ROBERT F Director | Award | 791 | — | Form 4 |
| May 4, 2026 | Feehery William F Director | Award | 791 | — | Form 4 |
| May 4, 2026 | BUTHMAN MARK A Director | Award | 791 | — | Form 4 |
| Apr 27, 2026 | Favorite Annette F Sr. VP & Chief HR Officer | Option | 2,817 | $235K | Form 4 |
| Apr 27, 2026 | Favorite Annette F Sr. VP & Chief HR Officer | Sale | 2,817 | $860K | Form 4 |
| Apr 27, 2026 | Winters Chad VP, Chief Accounting Officer | Option | 896 | $155K | Form 4 |
| Apr 27, 2026 | Winters Chad VP, Chief Accounting Officer | Sale | 896 | $269K | Form 4 |
| Feb 20, 2026 | Poussot Rodolphe Jean SVP, Strategy & Corporate Dev | Option | 383.382 | — | Form 4 |
| Feb 20, 2026 | Poussot Rodolphe Jean SVP, Strategy & Corporate Dev | Other | 129.545 | $31K | Form 4 |
| Feb 20, 2026 | Witherspoon Charles VP & Treasurer | Option | 60.22 | — | Form 4 |
| Feb 20, 2026 | Witherspoon Charles VP & Treasurer | Other | 22.069 | $5K | Form 4 |
| Feb 20, 2026 | Winters Chad VP, Chief Accounting Officer | Option | 89.328 | — | Form 4 |
| Feb 20, 2026 | Winters Chad VP, Chief Accounting Officer | Other | 30.184 | $7K | Form 4 |
| Feb 18, 2026 | Poussot Rodolphe Jean SVP, Strategy & Corporate Dev | Option | 82.299 | — | Form 4 |
Campbell Shane Alden
SVP, Proprietary Segment
Date
May 12
Shares
473.593
Price
—
Value
—
Campbell Shane Alden
SVP, Proprietary Segment
Date
May 12
Shares
134.927
Price
$312.07
Value
$42K
Campbell Shane Alden
SVP, Proprietary Segment
Date
May 12
Shares
295.995
Price
—
Value
—
Campbell Shane Alden
SVP, Proprietary Segment
Date
May 12
Shares
84.329
Price
$312.07
Value
$26K
Favorite Annette F
Sr. VP & Chief HR Officer
Date
Apr 27
Shares
2,817
Price
$83.47
Value
$235K
Favorite Annette F
Sr. VP & Chief HR Officer
Date
Apr 27
Shares
2,817
Price
$305.20
Value
$860K
Winters Chad
VP, Chief Accounting Officer
Date
Apr 27
Shares
896
Price
$173.22
Value
$155K
Winters Chad
VP, Chief Accounting Officer
Date
Apr 27
Shares
896
Price
$300.67
Value
$269K
Poussot Rodolphe Jean
SVP, Strategy & Corporate Dev
Date
Feb 20
Shares
383.382
Price
—
Value
—
Poussot Rodolphe Jean
SVP, Strategy & Corporate Dev
Date
Feb 20
Shares
129.545
Price
$241.12
Value
$31K
Witherspoon Charles
VP & Treasurer
Date
Feb 20
Shares
22.069
Price
$241.12
Value
$5K
Winters Chad
VP, Chief Accounting Officer
Date
Feb 20
Shares
89.328
Price
—
Value
—
Winters Chad
VP, Chief Accounting Officer
Date
Feb 20
Shares
30.184
Price
$241.12
Value
$7K
Poussot Rodolphe Jean
SVP, Strategy & Corporate Dev
Date
Feb 18
Shares
82.299
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About WST insider trading
WST insider trades
West Pharmaceutical Services, Inc. (WST) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Favorite Annette F (Sr. VP & Chief HR Officer), Winters Chad (VP, Chief Accounting Officer), Campbell Shane Alden (SVP, Proprietary Segment). Over the past 12 months, 5 insiders have filed transactions with the SEC. WST insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For West Pharmaceutical Services, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
WST insider trading · 5 questionsThe insiders of West Pharmaceutical Services, Inc. (WST) include executives and directors such as Favorite Annette F (Sr. VP & Chief HR Officer), Winters Chad (VP, Chief Accounting Officer), Campbell Shane Alden (SVP, Proprietary Segment), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026